Log in

Sign up
RO

Riku Ota

Global Payer Evidence Lead at Novo Nordisk

No bio yet

Links

Previous companies

Leo Pharma logo
Deloitte logo

Teams

+93

Research and Development

96 members

Timeline

  • Global Payer Evidence Lead

    April, 2024 - present

  • Health Economics Outcome Research (heor) Manager

    May, 2022

Related people